We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA 483 Finds Deficiencies at Baxter Healthcare Facility in Puerto Rico
FDA 483 Finds Deficiencies at Baxter Healthcare Facility in Puerto Rico
FDA’s San Juan district office has found numerous problems at a Baxter sterile drug manufacturing facility in Jayuya, Puerto Rico following a series of inspections in late August through early October.